Study guide
2.3 Essential Vitamins & Trace Elements
Certified Nutrition Support Clinician CNSC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Nutrition Screening, Dietary Evaluation & Energy Requirements
1.1 Nutrition Screening & Validated Risk Tools 1.2 Dietary History & Nutrient Intake Assessment 1.3 Energy Expenditure Estimation & Indirect Calorimetry
2 Chapter 2: Macronutrients, Micronutrients & Fluid Management
2.1 Protein Requirements & Nitrogen Balance 2.2 Fluid Requirements & Electrolyte Homeostasis 2.3 Essential Vitamins & Trace Elements
3 Chapter 3: Anthropometrics, Physical Exam & Malnutrition Consensus
3.1 Anthropometric Assessment & Body Composition 3.2 Nutrition-Focused Physical Examination (NFPE) 3.3 AND/ASPEN & GLIM Malnutrition Criteria
4 Chapter 4: Pediatric & Specialized Nutrition Assessment
4.1 Pediatric & Neonatal Nutrition Assessment 4.2 Biochemical Assessment, Visceral Proteins & Inflammation
5 Chapter 5: Enteral Nutrition Access & Tube Management
5.1 Enteral Access Modalities & Route Selection 5.2 Tube Placement Verification & Stoma Site Care
6 Chapter 6: Enteral Formulation, Regimen Design & Administration
6.1 Enteral Formula Classification & Selection 6.2 Enteral Delivery Methods & Infusion Schedules 6.3 Enteral Fluid Management & Free Water Requirements
7 Chapter 7: Enteral Complications & Medication Administration
7.1 Enteral Gastrointestinal Complications 7.2 Enteral Metabolic, Mechanical & Pulmonary Complications 7.3 Drug-Nutrient Interactions & Enteral Medication Delivery
8 Chapter 8: Parenteral Nutrition Indications, Access & Formulation Design
8.1 Parenteral Nutrition Indications & Venous Access Routes 8.2 Peripheral Parenteral Nutrition (PPN) Parameters 8.3 Central PN Macronutrient Formulation
9 Chapter 9: Parenteral Additives, Compounding & Physical Stability
9.1 Parenteral Electrolytes, Trace Elements & Vitamins 9.2 Calcium-Phosphate Solubility & Precipitation Risks 9.3 Physical Stability, Total Nutrient Admixtures & Filtration
10 Chapter 10: Parenteral Complications, CLABSI & Organ Toxicities
10.1 Central Line-Associated Bloodstream Infections & Mechanical Risks 10.2 Refeeding Syndrome Pathophysiology & Prevention 10.3 Parenteral Nutrition-Associated Liver Disease & Metabolic Bone Disease
11 Chapter 11: Critical Care, Obesity & Pulmonary Nutrition Support
11.1 Critical Illness, Sepsis & Trauma Nutrition 11.2 Nutrition Support in Obesity & Hypocaloric Feeding 11.3 Pulmonary Failure & Mechanical Ventilation 11.4 Nutrition Support Care Plans, Goals & Therapy Reassessment
12 Chapter 12: Organ Failure: Renal, Hepatic & Gastrointestinal Support
12.1 Acute Kidney Injury & Renal Replacement Therapy 12.2 Cirrhosis, Hepatic Encephalopathy & Acute Pancreatitis 12.3 Short Bowel Syndrome & Intestinal Failure
13 Chapter 13: Oncology, Surgical Care & Intestinal Failure
13.1 Oncology Nutrition & Cancer Cachexia 13.2 Perioperative Nutrition & Enhanced Recovery After Surgery (ERAS) 13.3 Enterocutaneous Fistulas & Severe Malabsorption
14 Chapter 14: Process Management, Compounding Safety & Home Nutrition Support
14.1 PN Order Verification, Compounding Safety & USP Standards 14.2 Home Nutrition Support (HNS) & Care Transitions 14.3 Nutrition Support Policies, Product Shortages & Patient Education
15 Chapter 15: Professional Practice, Ethics & Interdisciplinary Care
15.1 Ethical Principles & Withholding/Withdrawing Artificial Nutrition 15.2 The Interdisciplinary Nutrition Support Team 15.3 Quality Improvement, Malnutrition Documentation & Clinical Standards 15.4 Critical Appraisal of Nutrition Research & Evidence
2.3 Essential Vitamins & Trace Elements
Key Takeaways Explain This Topic AI
Thiamine (B1) serves as an obligatory co-factor for pyruvate dehydrogenase; malnourished patients require prophylactic parenteral thiamine (100-500 mg IV) prior to carbohydrate initiation to prevent fatal lactic acidosis and Wernicke encephalopathy.
High-output gastrointestinal fistulas and severe diarrhea produce massive zinc losses of 12-17 mg elemental zinc per liter of intestinal fluid, precipitating acrodermatitis enteropathica-like eruptions and impaired wound healing if unsupplemented.
Copper and manganese undergo primary hepatobiliary excretion; both elements must be withheld or substantially reduced in parenteral nutrition formulas for patients with cholestatic liver disease or hyperbilirubinemia to prevent hepatic toxicity and basal ganglia neurotoxicity.
Isolated folate supplementation without addressing concomitant vitamin B12 deficiency corrects macrocytic hematologic abnormalities while masking progressive, irreversible subacute combined degeneration of the spinal cord.
Parenteral iron is omitted from standard multi-trace element admixtures due to risks of emulsion destabilization, anaphylactoid reactions, and active promotion of bacterial proliferation during acute systemic infection.
Last updated: October 2026
2.3 Essential Vitamins & Trace Elements
Clinical Foundation: Micronutrients function as indispensable catalytic co-factors and structural elements in cellular metabolism. While macronutrients supply carbon skeletons and energy, they cannot be converted into ATP, synthesized into functional structural proteins, or utilized in cellular defense without vitamins and trace elements. In this independent study resource, specialized nutrition support demands precise micronutrient prescribing to avoid insidious deficiencies and toxicities across enteral and parenteral feeding modalities.
1. Water-Soluble Vitamins: Biochemical Roles & Clinical Deficiencies
Water-soluble vitamins are not stored in significant quantities within the body (with the notable exception of hepatic cobalamin stores). Consequently, clinical deficiency can emerge within weeks of inadequate intake during hypermetabolic stress.
1. Thiamine (Vitamin B 1 B_1 B 1 )
Active Coenzyme Form: Thiamine Pyrophosphate (TPP) .
Enzymatic Machinery: TPP is an obligatory co-factor for four critical multienzyme complexes:
Pyruvate Dehydrogenase (PDH): Converts glycolytic pyruvate into acetyl-CoA, providing the sole entry point for carbohydrate carbons into the Krebs (citric acid) cycle.
α \alpha α -Ketoglutarate Dehydrogenase: Catalyzes a rate-limiting step within the Krebs cycle.
Branched-Chain α \alpha α -Ketoacid Dehydrogenase (BCKD): Degrades leucine, isoleucine, and valine.
Transketolase: Operates within the hexose monophosphate shunt for NADPH synthesis.
Pathophysiology of Acute Refeeding Deficiency: In starved or severely malnourished patients, intracellular TPP stores are exhausted. When carbohydrates (dextrose) are administered without exogenous thiamine, rapid glycolysis produces large quantities of pyruvate. Without functional PDH, pyruvate cannot enter the Krebs cycle and is shunted into lactate via lactate dehydrogenase, causing catastrophic lactic acidosis .
Clinical Manifestations:
Wernicke Encephalopathy: The classic clinical triad consists of acute encephalopathy/confusion , gait ataxia , and ophthalmoplegia/nystagmus . If untreated, it progresses to irreversible Korsakoff syndrome , characterized by dense anterograde and retrograde amnesia with confabulation.
Cardiovascular Wet Beriberi: High-output congestive heart failure, severe peripheral vasodilation, lactic acidosis, and pulmonary edema.
Dry Beriberi: Symmetrical peripheral polyneuropathy with sensory loss and motor weakness.
Clinical Refeeding Protocol: Malnourished inpatients must receive 100 to 500 mg IV thiamine daily for 3 to 5 days , initiated prior to or concurrently with the start of dextrose-containing infusions or enteral formulas.
2. Vitamin C (Ascorbic Acid)
Physiological Role: Required as an electron donor for prolyl and lysyl hydroxylases, enzymes responsible for hydroxylating proline and lysine residues during triple-helix collagen synthesis. Also essential for carnitine biosynthesis, norepinephrine synthesis, and free radical scavenging.
Deficiency (Scurvy): Characterized by impaired collagen cross-linking: perifollicular petechiae, coiled "corkscrew" hairs, bleeding and swollen gingiva, arthralgias, impaired wound healing, and surgical wound dehiscence.
High-Demand Clinical States: Requirements increase substantially in major thermal burns (500 to 1000 mg/day required to support extensive dermal neo-collagenation), severe polytrauma, and patients undergoing continuous renal replacement therapy (CRRT) or chronic hemodialysis due to rapid dialytic clearance of water-soluble molecules.
3. Folate (Vitamin B 9 B_9 B 9 ) & Cobalamin (Vitamin B 12 B_{12} B 12 )
Cellular Synergy: Folate (as tetrahydrofolate) and vitamin B 12 B_{12} B 12 (as methylcobalamin) act synergistically in one-carbon metabolism and nucleotide synthesis (converting homocysteine to methionine and dUMP to dTMP).
Hematologic Findings: Both deficiencies produce identical megaloblastic, macrocytic anemia (elevated Mean Corpuscular Volume [MCV > 100 fL >100\text{ fL} > 100 fL ]) with hypersegmented polymorphonuclear neutrophils on peripheral blood smears.
Neurologic Divergence (Subacute Combined Degeneration): Vitamin B 12 B_{12} B 12 is independently required for methylmalonyl-CoA mutase (converting methylmalonyl-CoA to succinyl-CoA for myelin maintenance). Vitamin B 12 B_{12} B 12 deficiency causes Subacute Combined Degeneration (SCD) of the spinal cord—demyelination of the dorsal (posterior) and lateral columns, presenting with peripheral paresthesias, sensory ataxia, loss of vibratory and position sense, and spastic paraparesis. Folate deficiency causes no neurological deficits.
Gastrointestinal Anatomy of B 12 B_{12} B 12 Absorption: Dietary B 12 B_{12} B 12 binds gastric intrinsic factor (IF) secreted by parietal cells in the gastric body/fundus. The stable B 12 B_{12} B 12 -IF complex travels through the small intestine to bind specialized cubilin receptors located exclusively in the terminal ileum .
Surgical Risk: Resection of > 50 to 100 cm >50\text{ to }100\text{ cm} > 50 to 100 cm of terminal ileum (e.g., in Crohn's disease) or total gastrectomy permanently abolishes B 12 B_{12} B 12 absorption, mandating lifelong monthly intramuscular ( 1000 mcg 1000\text{ mcg} 1000 mcg ) or daily high-dose crystalline oral ( 1000 − 2000 mcg 1000-2000\text{ mcg} 1000 − 2000 mcg ) repletion.
The "Folate Trap" Warning: Administering high-dose folic acid alone to a patient with unrecognized B 12 B_{12} B 12 deficiency will bypass the enzymatic block in purine synthesis, hematologically resolving the macrocytic anemia while allowing progressive, irreversible spinal cord demyelination to advance undetected.
2. Fat-Soluble Vitamins (A, D, E, K): Absorption & Pathophysiology
Fat-soluble vitamins depend on intact lipid digestive and absorptive machinery: dietary lipid emulsification, bile salt micellar incorporation, pancreatic lipase hydrolysis, enterocyte uptake, and lymphatic chylomicron assembly.
Malabsorptive Risk Populations
Deficiencies in fat-soluble vitamins develop rapidly in clinical disorders compromising bile acid or pancreatic enzyme delivery:
Cholestatic liver disease & biliary obstruction (impaired bile acid secretion into the duodenum).
Exocrine pancreatic insufficiency (chronic pancreatitis, cystic fibrosis).
Short bowel syndrome (SBS) & extensive mucosal disease (celiac sprue, refractory Crohn's disease).
Bariatric malabsorptive operations (biliopancreatic diversion with duodenal switch, Roux-en-Y gastric bypass).
Physiological Summary & Deficiencies
Vitamin A (Retinoids / Carotenoids): Essential for retinal rhodopsin synthesis (vision), mucosal epithelial differentiation, and immune barrier defense. Deficiency causes nyctalopia (night blindness) , xerophthalmia (dry conjunctiva), Bitot's spots (foamy keratin plaques on bulbar conjunctiva), and follicular hyperkeratosis.
Vitamin D (Calciferols): Hydroxylated to 25-hydroxyvitamin D [25(OH)D] in the liver and 1,25-dihydroxyvitamin D [ 1 , 25 ( O H ) 2 D 1,25(OH)_2D 1 , 25 ( O H ) 2 D ] in the kidney; enhances intestinal calcium and phosphorus absorption. Deficiency causes osteomalacia in adults and rickets in children.
Vitamin E (Tocopherols): Primary lipophilic antioxidant preventing free radical peroxidation of polyunsaturated fatty acids in cell membranes. Deficiency causes hemolytic anemia , spinocerebellar ataxia, peripheral neuropathy, and loss of proprioception (resembling Friedreich ataxia).
Vitamin K (Phylloquinone K 1 K_1 K 1 / Menaquinone K 2 K_2 K 2 ): Co-factor for hepatic γ \gamma γ -glutamyl carboxylase, which carboxylates glutamic acid residues on coagulation factors II, VII, IX, and X , as well as regulatory anticoagulants Protein C and Protein S .
Vitamin K & Warfarin Anticoagulation Interactions
Warfarin exerts its therapeutic anticoagulant effect through competitive inhibition of vitamin K epoxide reductase (VKORC1) , blocking the recycling of active vitamin K hydroquinone. Standard commercial adult parenteral multivitamin formulations (e.g., INFUVITE Adult) supply 150 mcg of phylloquinone daily to prevent parenteral deficiency.
Clinical Dilemma: In patients receiving therapeutic warfarin, changes in specialized nutrition formulas can destabilize the International Normalized Ratio (INR).
Practice Rule: Clinicians should maintain consistency of daily vitamin K intake rather than attempting to completely eliminate vitamin K from nutrition support regimens. Abrupt removal or erratic reintroduction of vitamin K induces dangerous fluctuations between thrombosis and hemorrhage.
3. Essential Trace Elements in Specialized Nutrition Support
Trace elements are inorganic micronutrients required in milligram or microgram amounts that serve as active catalytic centers for vital metalloenzymes.
1. Zinc ( Z n Zn Z n )
Function: Co-factor for over 300 metalloenzymes (DNA/RNA polymerases, alkaline phosphatase, carbonic anhydrase, matrix metalloproteinases); regulates cellular proliferation, wound re-epithelialization, and T-lymphocyte function.
Gastrointestinal Fluid Losses: Duodenal, pancreatic, and small intestinal secretions are rich in zinc, containing 12 to 17 mg of elemental zinc per liter of fluid . Patients with high-output enterocutaneous fistulas , high-output stomas, or severe secretory diarrhea rapidly deplete zinc stores within days.
Replacement Guideline: Supplement 12 to 17 mg of elemental zinc per liter of small bowel fluid loss in addition to baseline maintenance needs ( 3 to 5 mg/day 3\text{ to }5\text{ mg/day} 3 to 5 mg/day IV in PN).
Deficiency Signs: Acrodermatitis enteropathica-like lesions (vesiculobullous, erythematous, and crusted plaques distributed periorificially around the mouth, eyes, perineum, and over distal extremities), alopecia, delayed wound healing, loss of taste acuity (hypogeusia), and severe diarrhea.
2. Copper ( C u Cu C u )
Function: Integral component of ceruloplasmin (ferroxidase required for oxidizing ferrous F e 2 + Fe^{2+} F e 2 + to ferric F e 3 + Fe^{3+} F e 3 + for transferrin binding and iron transport), cytochrome c oxidase (ATP synthesis), and lysyl oxidase (collagen and elastin cross-linking).
Deficiency Signs: Microcytic hypochromic or normocytic anemia completely refractory to oral or intravenous iron supplementation, severe absolute neutropenia/leukopenia , and sensory ataxia with peripheral neuropathy mirroring subacute combined degeneration.
Biliary Excretion & Toxicity Warning: Copper is excreted almost exclusively ( >80% ) via the biliary tract . In cholestatic liver disease, severe biliary obstruction, or conjugated hyperbilirubinemia (total serum bilirubin > 2 − 3 mg/dL >2-3\text{ mg/dL} > 2 − 3 mg/dL ), copper clearance halts. Continued standard parenteral supplementation causes progressive hepatic accumulation, liver necrosis, and systemic toxicity. Withhold or reduce copper in parenteral formulations during active cholestasis.
3. Chromium ( C r Cr C r )
Function: Biologically active as part of chromodulin (glucose tolerance factor), which binds the intracellular domain of insulin receptors, amplifying tyrosine kinase activity and facilitating cellular glucose uptake.
Deficiency Signs: Severe, refractory insulin-resistant hyperglycemia (requiring massive exogenous insulin infusions in previously non-diabetic patients on long-term home TPN without trace elements), hyperlipidemia, weight loss, and metabolic encephalopathy.
4. Selenium ( S e Se S e )
Function: Essential constituent of the amino acid selenocysteine, incorporated into glutathione peroxidase (the primary cellular antioxidant enzyme detoxifying hydrogen peroxide) and iodothyronine deiodinases (converting thyroxine T 4 T_4 T 4 to active T 3 T_3 T 3 ).
Deficiency Signs: Severe congestive cardiomyopathy ( Keshan disease ), proximal skeletal muscle myopathy, pain, and loss of nail pigmentation with macrocytosis.
5. Manganese ( M n Mn M n )
Function: Co-factor for mitochondrial superoxide dismutase (SOD2), pyruvate carboxylase, and arginase (urea cycle).
Biliary Excretion & Basal Ganglia Neurotoxicity: Like copper, manganese is eliminated almost entirely through the biliary tree. In cholestasis or long-term parenteral nutrition, manganese accumulates in the brain—specifically within the basal ganglia (globus pallidus) . This accumulation appears as bilateral hyperintensity on T1-weighted MRI images.
Clinical Manifestations: Severe extrapyramidal movement disorders resembling Parkinson's disease (resting tremor, masked facies, rigidity, choreoathetosis), dysarthria, and psychiatric disturbances ("manganese madness"). Withhold or severely restrict manganese in parenteral nutrition for patients with cholestasis.
6. Iron ( F e Fe F e )
Parenteral Safety Contraindications: Adult commercial multi-trace element admixtures deliberately exclude iron . Routine addition of iron to parenteral nutrition is avoided due to three critical clinical hazards:
Anaphylactoid Reactions: Historical risk of severe hypersensitivity associated with iron dextran.
Total Nutrient Admixture (TNA) Cracking: Trivalent cations ( F e 3 + Fe^{3+} F e 3 + ) destabilize the negative zeta potential of intravenous lipid emulsion droplets, causing coalescence and emulsion "cracking" (forming fatal pulmonary fat emboli).
Infection / Sepsis Risk: Free elemental iron serves as an essential virulence nutrient for pathogenic bacteria ( Escherichia coli , Klebsiella pneumoniae , Yersinia enterocolitica , Staphylococcus aureus ). Parenteral iron is strictly contraindicated during active, uncontrolled bacteremia or severe sepsis.
4. Trace Element Toxicity, Deficiency & Prescribing Matrix
Trace Element Normal Physiological Role Clinical Deficiency Manifestations Primary Excretion Pathway Clinical Prescribing Rules & Toxicity Warnings
Zinc ( Z n Zn Z n ) Metalloenzyme co-factor ( > 300 >300 > 300 ), wound healing, DNA/RNA synthesis Acrodermatitis enteropathica rash, alopecia, hypogeusia, poor wound healing Intestinal / Pancreatic secretions Add 12 to 17 mg elemental zinc per liter of small bowel fluid loss (enterocutaneous fistula or severe diarrhea).
Copper ( C u Cu C u ) Ceruloplasmin ferroxidase, iron transport, cytochrome c oxidase Microcytic anemia refractory to iron, neutropenia, myeloneuropathy Biliary (>80%) Withhold or reduce in cholestasis or hyperbilirubinemia (bilirubin > 2 − 3 mg/dL >2-3\text{ mg/dL} > 2 − 3 mg/dL ) to prevent hepatic necrosis.
Chromium ( C r Cr C r ) Chromodulin; enhances insulin receptor tyrosine kinase activity Severe insulin-resistant hyperglycemia, hyperlipidemia, neuropathy Renal Monitor blood glucose in long-term home TPN; supplement to restore insulin sensitivity.
Selenium ( S e Se S e ) Glutathione peroxidase; cellular antioxidant defense, thyroid deiodinase Keshan disease (fatal cardiomyopathy), skeletal myopathy, macrocytosis Renal Routine inclusion in PN; essential for burn, trauma, and long-term TPN patients.
Manganese ( M n Mn M n ) Mitochondrial SOD, arginase, glycosyltransferases Skeletal abnormalities, impaired lipid metabolism (rare) Biliary (>95%) Withhold in cholestasis ; accumulates in basal ganglia causing irreversible Parkinsonian neurotoxicity.
Iron ( F e Fe F e ) Oxygen delivery (hemoglobin/myoglobin), electron transport chain Microcytic hypochromic anemia, fatigue, koilonychia Desquamation / Blood loss Omitted from standard PN trace admixtures ; destabilizes 3-in-1 lipid emulsions; contraindicated in active sepsis .